ANI Pharmaceuticals (ANIP) 10-Q2006 Q1 Quarterly report

Filed: 12 May 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: abuse, accrual, aesthetic, alleging, alum, amortized, attorney, Bank, BioOral, body, buccal, calculation, calendar, carefully, cautionary, charge, Chicago, Circuit, Civil, clarify, complaint, contemplate, Cook, correct, County, couple, declaratory, discount, discrimination, dividend, Dr, dramatically, duty, EEOC, entirety, exploring, expressly, external, Factor, fiduciary, field, formally, global, GMP, half, harbor, head, heading, Hemophilia, hereunto, inaccurate, intrinsic, IV, IX, Journal, LaSalle, Leah, Lehman, lower, MATC, medicine, Nebraska, neck, November, Occupational, Opportunity, pending, predict, project, pulmonary, punitive, ratably, reached, reinstatement, relief, renew, resolution, retaliation, senior, size, Street, Structured, subordinate, successor, summary, tax, Title, Trust, trustee, ultimate, ultimately, unrecognized, unspecified, untimely, unvested, Vice, vigorously, VII, Wall, yield

Removed: abroad, absence, Academic, Alternatively, altogether, applied, assure, Australia, biotechnology, bringing, capable, characterized, chemical, collaboration, commercialize, competition, conduct, conducting, consideration, continual, costly, credibility, data, dealing, decline, deemed, delayed, determine, disclose, discovered, earlier, enterprise, environment, evaluate, expensive, facility, fail, female, filing, furniture, gain, governmental, granting, greater, hiring, identify, inconclusive, inherent, insufficient, insulin, intense, introduce, investing, lengthy, limit, Malaysia, manufacture, manufacturer, meet, menopausal, multiple, negative, newly, obligated, occurrence, order, paid, partial, patch, percentage, placement, prevent, prevention, previously, private, produced, profitability, protection, protective, quickly, rapidly, regulation, replacement, return, slightly, sophisticated, substantially, succeed, surveillance, target, tested, thereunto, transition, typically, varying, withdrawal, wrong

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ANIP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Certification of CFO Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of BioSante Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Phillip B. Donenberg, Chief Financial Officer, Treasurer and Secretary of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2005

/s/ Phillip B. Donenberg

Phillip B. Donenberg

Chief Financial Officer, Treasurer and Secretary